Stock News in Focus: Seneca Biopharma (NASDAQ:SNCA)

Seneca Biopharma (NASDAQ:SNCA) stock observed trading -94.23% off 52-week high price. On the other end, the stock has been noted 33.98% away from low price over the last 52-weeks. The stock disclosed a move of -21.35% away from 50 day moving average and -63.54% away from 200 day moving average. Moving closer, we can see that shares have been trading 4.11% off 20-day moving average. It has market cap of $5.45M.

On April 7, 2020, Seneca Biopharma (NASDAQ:SNCA) a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, provided a status update on the company’s non-GCP Phase II trial evaluating the use of its proprietary neural stem cells, NSI-566, for the treatment of chronic ischemic stroke. The trial is being conducted at the BaYi Brain Hospital in Beijing, China. As of March 31, 2020, follow-up assessments had been completed on 60% of the subjects in the trial and the company continues to expect data readout to be available during the second half of 2020, as previously disclosed.

This trial is an important step in the development of this therapy for the global market, especially China, where ischemic stroke is a leading cause of death and disability, said Dr. Ken Carter, Executive Chairman of Seneca. We remain on-track with our prior guidance, thanks to the physicians and clinical trial staff who have worked diligently to conduct this study, while maintaining their own safety and that of our patients during difficult circumstances brought about by the COVID-19 pandemic.

About Seneca Biopharma

Seneca Biopharma, is a clinical-stage biopharmaceutical company developing novel treatments for diseases of high unmet medical need. The Company is in the process of transforming the organization through the acquisition or in-licensing of new science and technologies, to develop with the goal of providing meaningful therapies for patients.

The USA based company Seneca Biopharma moved with change of 0.43% to $0.67 with the total traded volume of 362700 shares in recent session versus to an average volume of 1.87M. The stock was observed in the 5days activity at 1.18%. The one month performance of stock was -10.12%. SNCA’s shares are at -42.25% for the quarter and driving a -92.39% return over the course of the past year and is now at -32.33% since this point in 2018.  Right now the stock beta is 1.53. The average volatility for the week and month was at 15.44% and 15.57% respectively. There are 8.14M shares outstanding and 8.14M shares are floated in market.

Leave a Reply

Your email address will not be published. Required fields are marked *